Non-Small Cell Lung Cancer
3 stories
-
healthDeep Learning Outperforms Radiomics in Predicting Immunotherapy Outcomes in NSCLC
Deep learning models show superior accuracy over radiomics in predicting immunotherapy outcomes for metastatic NSCLC, promising better treatment personalization.
-
healthAge Alone Should Not Rule Out Lung Cancer Surgery
Study shows lung cancer surgery is safe and effective for carefully selected patients aged 80 and older with early-stage NSCLC.
-
healthMorning Immunotherapy Tied to Longer Survival in Advanced Cancer
New analysis suggests timing of immune checkpoint inhibitor infusions may impact patient outcomes, with earlier administration linked to better survival.